MALLINCKRODT PLC(NYSEARCA:MNK) stock News

MNK Latest News, Press Relases and Analysis

All

Press Releases

3 months ago - By: The Business Journals

Endo board approves millions in bonuses to keep key execs amid Mallinckrodt merger

4 months ago - By: The Business Journals

Mallinckrodt to merge with another drugmaker, Endo, in nearly $7B deal

4 months ago - By: Benzinga - Mentions: NDOI

Mallinckrodt, Endo Merger To Create Pharma Entity Valued At $7 Billion

4 months ago - By: Yahoo Finance

Drugmakers Mallinckrodt, Endo to Merge, Plan NYSE Listing

4 months ago - By: Yahoo Finance

Mallinckrodt, Endo Enter $6.7 Billion Merger Deal as Drug Makers Plan New US Listing

4 months ago - By: The Business Journals

Endo agrees to merge with Mallinckrodt in deal valued at almost $7B

4 months ago - By: Yahoo Finance

Mallinckrodt to take over Endo in deal valued at $6.7 billion

4 months ago - By: CNBC

Drugmakers Mallinckrodt and Endo to merge in nearly $7 billion deal

4 months ago - By: Bloomberg - Mentions: NDOI

Mallinckrodt Pharma, Endo Reach Deal for $6.7 Billion Merger

4 months ago - By: Yahoo Finance

Drugmakers Mallinckrodt and Endo to merge in nearly $7 billion deal

4 months ago - By: Bloomberg - Mentions: NDOI

Drugmakers Mallinckrodt and Endo Are in Talks to Merge

a year ago - By: Benzinga - Mentions: AZN SLN

What's Going On With Silence Therapeutics Stock Today?

2 years ago - By: Seeking Alpha

Mallinckrodt to discontinue StrataGraft due to slow uptake (OTCMKTS:MNKTQ)

2 years ago - By: Seeking Alpha

Mallinckrodt emerges from bankruptcy (OTCMKTS:MNKTQ)

2 years ago - By: Yahoo Finance

UPDATE 1-Drugmaker Mallinckrodt emerges from bankruptcy

2 years ago - By: Yahoo Finance

Drugmaker Mallinckrodt emerges from bankruptcy

2 years ago - By: Reuters

Drugmaker Mallinckrodt emerges from bankruptcy

2 years ago - By: Seeking Alpha

Mallinckrodt sees emerging from Chapter 11 by end of year (MNKTQ)

2 years ago - By: Bloomberg

Activist Hedge Funds Get Less Time to Disclose 5%-Plus Stakes Under SEC Rule

2 years ago - By: Bloomberg

Trump Jurors Need Extra Protection in 2020 Election Case, Prosecutors Say

2 years ago - By: Bloomberg

KKR Considers $4.2 Billion Sale of European Car Park Operator Q-Park

2 years ago - By: Bloomberg

Lithuanian Parliamentary Speaker to Visit Taiwan This Month

2 years ago - By: Bloomberg

Housing Groups, Mortgage Lenders Urge Powell to Halt Fed Hikes

2 years ago - By: Bloomberg - Mentions: WFC

Mallinckrodt Approved to End Bankruptcy, Reduce Opioid Payments

2 years ago - By: Yahoo Finance

Mallinckrodt gets approval for restructuring, $1 billion cut to opioid settlement

2 years ago - By: Reuters

Mallinckrodt gets approval for restructuring, $1 billion cut to opioid settlement

2 years ago - By: Marketwatch

: Mallinckrodt bankruptcy plan gains approval from federal court

2 years ago - By: Bloomberg

Japan’s Kokusai Electric Sets IPO Range Below Initial Guidance

2 years ago - By: Seeking Alpha

Mallinckrodt said to weigh sale of opioid business - WSJ

2 years ago - By: Yahoo Finance

Bankrupt drugmaker Mallinckrodt considers sale of opioid business - WSJ

2 years ago - By: Reuters

Bankrupt drugmaker Mallinckrodt considers sale of opioid business - WSJ

2 years ago - By: Yahoo Finance

UPDATE 1-Bankrupt drugmaker Mallinckrodt considers sale of opioid business - WSJ

2 years ago - By: Faruqi & Faruqi, LLP

MALLINCKRODT DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Mallinckrodt To Contact Him Directly To Discuss Their Options

2 years ago - By: The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mallinckrodt plc (MNK)

2 years ago - By: Yahoo Finance

Generic drugmakers start shipping copies of Takeda's ADHD drug Vyvanse

2 years ago - By: Seeking Alpha

Mallinckrodt gets access to $150M of new financing

2 years ago - By: Bloomberg

MALLINCKRODT PLC (MNK) Stock News

MNK Latest News, Press Relases and Analysis

Endo board approves millions in bonuses to keep key execs amid Mallinckrodt merger

Mallinckrodt to merge with another drugmaker, Endo, in nearly $7B deal

Mallinckrodt, Endo Merger To Create Pharma Entity Valued At $7 Billion

Drugmakers Mallinckrodt, Endo to Merge, Plan NYSE Listing

Mallinckrodt, Endo Enter $6.7 Billion Merger Deal as Drug Makers Plan New US Listing

Endo agrees to merge with Mallinckrodt in deal valued at almost $7B

Mallinckrodt to take over Endo in deal valued at $6.7 billion

Drugmakers Mallinckrodt and Endo to merge in nearly $7 billion deal

Mallinckrodt Pharma, Endo Reach Deal for $6.7 Billion Merger

Drugmakers Mallinckrodt and Endo to merge in nearly $7 billion deal

Drugmakers Mallinckrodt and Endo Are in Talks to Merge

What's Going On With Silence Therapeutics Stock Today?

Mallinckrodt to discontinue StrataGraft due to slow uptake (OTCMKTS:MNKTQ)

Mallinckrodt emerges from bankruptcy (OTCMKTS:MNKTQ)

UPDATE 1-Drugmaker Mallinckrodt emerges from bankruptcy

Drugmaker Mallinckrodt emerges from bankruptcy

Drugmaker Mallinckrodt emerges from bankruptcy

Mallinckrodt sees emerging from Chapter 11 by end of year (MNKTQ)

Activist Hedge Funds Get Less Time to Disclose 5%-Plus Stakes Under SEC Rule

Trump Jurors Need Extra Protection in 2020 Election Case, Prosecutors Say

KKR Considers $4.2 Billion Sale of European Car Park Operator Q-Park

Lithuanian Parliamentary Speaker to Visit Taiwan This Month

Housing Groups, Mortgage Lenders Urge Powell to Halt Fed Hikes

Mallinckrodt Approved to End Bankruptcy, Reduce Opioid Payments

Mallinckrodt gets approval for restructuring, $1 billion cut to opioid settlement

Mallinckrodt gets approval for restructuring, $1 billion cut to opioid settlement

: Mallinckrodt bankruptcy plan gains approval from federal court

Japan’s Kokusai Electric Sets IPO Range Below Initial Guidance

Mallinckrodt said to weigh sale of opioid business - WSJ

Bankrupt drugmaker Mallinckrodt considers sale of opioid business - WSJ

Bankrupt drugmaker Mallinckrodt considers sale of opioid business - WSJ

UPDATE 1-Bankrupt drugmaker Mallinckrodt considers sale of opioid business - WSJ

MALLINCKRODT DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Mallinckrodt To Contact Him Directly To Discuss Their Options

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mallinckrodt plc (MNK)

Generic drugmakers start shipping copies of Takeda's ADHD drug Vyvanse

Mallinckrodt gets access to $150M of new financing

Denmark’s Government Expects Financing Need to Decline in 2024